Bertis
PrivateLast Round
Private Equity
Feb 26, 2024
Est. Valuation
$109.56M
Total Funding Raised
$53.73M
Company Overview
Bertis operates in Healthcare & Life Sciences and is based in Seongnam-si. Its latest recorded funding round was a Private Equity round in February 2024.
Bertis is a biotechnology company that develops proteomics-based precision medicine technology and AI-driven diagnostic solutions for cancer and other major diseases.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Precision Medicine, Drug Discovery, Medical AI, Healthcare Analytics
Business Model
B2B
Customer Profile
Services & Consulting, Usage-Based SaaS
AI Layer
Application
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Bertis Comparables
Compare Bertis with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Bcal Diagnostics Ltd | 77% | |
| PrognomiQ | 77% | |
| Illumina, Inc. | 76% |
For institutional investors. Book with your work email.
Bertis Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Private Equity | Feb 26, 2024 | ||||
| Corporate Funding | Jun 3, 2021 | ||||
| Series B | Dec 28, 2020 | ||||
| Series A | Oct 31, 2018 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
Bertis Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| BNH INVESTMENT | Series B, Private Equity |
| Smilegate Investment | Series B, Series A |
| Focus Assets Management | Series B |
| KCLAVIS Investment | Series B |
| Korea Investment Partners | Series A |
| Winvest Venture Capital | Private Equity |
| Premier Partners | Series B, Private Equity |
For institutional investors. Book with your work email.
Market signals
Structured signals derived from secondary market and firmographic data.
- May 2, 2025
Monthly visitors increased 58% MoM, reaching 1.4K.
- Apr 9, 2025
Monthly visitors grew 371% MoM, reaching 885.
For institutional investors. Book with your work email.
Bertis Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Bertis's valuation, stock price, and market status.
Is Bertis a public or private company?
Bertis is a private company.
What is the current stock price of Bertis?
Bertis is a private company, so its shares have no public market price. Caplight tracks Bertis's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Bertis worth (valuation)?
Bertis's valuation is estimated at $109.6M based on funding round data.
Can I buy Bertis stock?
Bertis shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Bertis's last funding round?
Bertis's most recent funding round was Private Equity on February 26, 2024.
Who are the main investors in Bertis?
Key investors in Bertis include BNH INVESTMENT, Smilegate Investment, Focus Assets Management, KCLAVIS Investment, Korea Investment Partners.
Will Bertis IPO soon?
No public IPO plans have been announced for Bertis.
How can I track Bertis secondary market activity?
Caplight tracks bids, offers, and trades in Bertis's shares on secondary markets.